Whenever possible, avoid B12 supplements that contain cyanocobalamin and opt for supplements that contain methylcobalamin
As with any injection, there are some possible side effects and risks that come with receiving a lipotropic shot
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
Label information also notes storage at controlled room temperature and protection from light
Caution is advised in patients with Leber optic atrophy, a genetic disorder caused by chronic cyanide intoxication (such as from smoking, alcohol or some plants), against the use of cyano-B12 due to its cyanide moiety, whilst hydroxo-B12 is a cyanide antagonist and can therefore be used in these patients
Our guides to heartburn on tirzepatide and semaglutide acid reflux cover management options including dietary adjustments and positioning strategies